Clinical Trial Update: A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of ML-007C-MA for treating psychosis associated with Alzheimer's disease and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Psychosis

Drugs mentioned

• ML-007C-MA

Snippet

Sponsor: MapLight Therapeutics | Conditions: Psychosis Associated With Alzheimer's Disease | Phase 2 | Status: RECRUITING